![Thomas Schenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Thomas Schenk served as the Chief Medical Officer at ImpediMed Ltd. from 2022 to 2023.
Prior to this, he obtained undergraduate degrees from Cornell University and Jacobs School of Medicine & Biomedical Sciences.
Ehemalige bekannte Positionen von Thomas Schenk
| Unternehmen | Position | Ende |
|---|---|---|
| IMPEDIMED LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 26.09.2023 |
Ausbildung von Thomas Schenk
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
 Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
